NEWPORT BEACH, Calif.  – American Vanguard Corporation announced that its wholly-owned subsidiary AMVAC Chemical Corporation has licensed rights to Summit Chemical Corporation’s Bti Briquets for the global professional mosquito larvicide market.

Bti Briquets are a unique, sustained release formulation of the naturally occurring bacterium Bacillus thuringiensis israelensis (Bti), a safe bio-rational larvicide, according to AMVAC. This product provides a versatile, efficient, cost-effective and environmentally compliant treatment which has contributed to successful larvicide control for more than three decades in U.S. and international public health markets.

Vince Pascarelli, AMVAC’s director of International Business Development commented: “This is a strategic growth area for AMVAC, and we are pleased to be aligned with Summit, a well-respected leader in the production and supply of mosquito larvicides. This agreement will form the cornerstone of a strategic partnership with Summit which is expected to provide AMVAC with a pipeline of new larvicides manufactured by Summit for the public health mosquito control market.”

Jeff Alvis, business manager for AMVAC’s Environmental Products business commented, “AMVAC Environmental Products’ well known Dibrom® Concentrate and Trumpet®EC are recognized as the most effective products for adult mosquito control. The company’s entry into the larvicide market broadens our offering for existing customers and provides the opportunity to reach new customers in domestic markets and abroad. The prospect of developing several new larvicide products in collaboration with Summit, will provide AMVAC with a very comprehensive set of products for mosquito control programs worldwide.”

Jonathan Cohen, president of Summit Chemical, added, “Since the introduction of Bti Briquets, Summit has solely manufactured, marketed and serviced this product to the Vector Control Industry. While the Bti Briquet product will remain unchanged, AMVAC is positioned to provide a greater level of service to the professional public health markets through their geographical reach and resource capacity. We expect this alliance to benefit our two companies through increased market penetration, new product development and also provide the global Vector Control and Public Health community with excellent product availability, timely application information and responsive customer service.”